Literature DB >> 14677841

Yield of casual contact investigation by the hour.

C Greenaway1, M Palayew, D Menzies.   

Abstract

OBJECTIVE: Among casual contacts of tuberculosis (TB) patients, to assess how duration of contact, prior mycobacterial exposure, and performance of one or two tuberculin skin tests (TST), affect the likelihood that a positive TST represents conversion.
METHODS: Published estimates of mycobacterial prevalence and BCG coverage, and their effect on single or repeated TSTs, were used to calculate baseline prevalence of TST reactions in four populations commonly encountered in North American contact investigations. Using published estimates of hourly risk of TB infection, the probability that a positive TST represented conversion was calculated.
RESULTS: Among casual contacts with 20 hours of exposure, the likelihood that a single positive TST performed after 8 weeks represented conversion was 77% in persons from populations with low prior mycobacterial exposure, but only 6-8% in foreign-born populations. If tuberculin testing was performed immediately and then again 8 weeks post-exposure, 14-38% of all positive tests would be due to boosting, related to prior exposure to mycobacteria or BCG. If one TST, performed 8 weeks after exposure, was positive in casual contacts from populations with high prevalence of prior mycobacterial exposures, the likelihood of true conversion was less than 40%, even after 200 hours of exposure.
CONCLUSIONS: A single TST performed 8 weeks after the end of exposure among casual contacts will detect all true conversions, and minimize misdiagnosis due to boosting. The decision to perform TST on casual contacts should consider the likelihood of prior mycobacterial exposure in the population, as well as the duration of exposure.

Entities:  

Mesh:

Year:  2003        PMID: 14677841

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  Contacts of retreatment tuberculosis cases with a prior poor treatment outcome are at increased risk of latent tuberculosis infection.

Authors:  Davit Baliashvili; Matthew J Magee; Russell R Kempker; Giorgi Kuchukhidze; Ana Aslanikashvili; Henry M Blumberg
Journal:  Int J Infect Dis       Date:  2015-12-25       Impact factor: 3.623

2.  A population-based tuberculosis contact investigation in the country of Georgia.

Authors:  D Baliashvili; R R Kempker; H M Blumberg; G Kuchukhidze; T Merabishvili; A Aslanikashvili; M J Magee
Journal:  Public Health Action       Date:  2018-09-21

3.  Contact investigation in households of patients with tuberculosis in Hanoi, Vietnam: a prospective cohort study.

Authors:  Gregory James Fox; Nguyen Viet Nhung; Dinh Ngoc Sy; Luu Thi Lien; Nguyen Kim Cuong; Warwick John Britton; Guy Barrington Marks
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

Review 4.  Contact investigation for tuberculosis: a systematic review and meta-analysis.

Authors:  Gregory J Fox; Simone E Barry; Warwick J Britton; Guy B Marks
Journal:  Eur Respir J       Date:  2012-08-30       Impact factor: 16.671

5.  Household Contact Screening and Yield of Tuberculosis Cases-A Clinic Based Study in Chennai, South India.

Authors:  Dina Nair; Nandita Rajshekhar; Joel Shyam Klinton; Basilea Watson; Banurekha Velayutham; Jaya Prasad Tripathy; Mohideen Shaheed Jawahar; Soumya Swaminathan
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

6.  Tuberculosis infection among youths in overcrowded university hostels in Kenya: a cross-sectional study.

Authors:  Teresia Maina; Annie Willetts; Moses Ngari; Abdullahi Osman
Journal:  Trop Med Health       Date:  2021-12-28

7.  Prospective 1-year follow-up study of all cured, new sputum smear positive tuberculosis patients under the Revised National Tuberculosis Control Program in Hyderabad, Telangana State, India.

Authors:  Neeta Mathur; Chakrapani Chatla; Saba Syed; Yogesh Patel; Snigdha Pattnaik; Dilip Mathai; Adepu Rajesham
Journal:  Lung India       Date:  2019 Nov-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.